Prolactin prevents hepatocellular carcinoma by restricting innate immune activation of c-Myc in mice
Women are more resistant to hepatocellular carcinoma (HCC) than men despite equal exposure to major risk factors, such as hepatitis B or C virus infection. Female resistance is hormone-dependent, as evidenced by the sharp increase in HCC incidence in postmenopausal women who do not take hormone repl...
Main Authors: | Hartwell, Hadley J. (Author), Petrosky, Keiko Y. (Author), Fox, James G. (Contributor), Horseman, Nelson D. (Author), Rogers, Arlin B. (Author) |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Biological Engineering (Contributor), Massachusetts Institute of Technology. Division of Comparative Medicine (Contributor) |
Format: | Article |
Language: | English |
Published: |
National Academy of Sciences (U.S.),
2015-03-04T15:55:33Z.
|
Subjects: | |
Online Access: | Get fulltext |
Similar Items
-
Acute Dietary Restriction Acts via TOR, PP2A, and Myc Signaling to Boost Innate Immunity in Drosophila
by: Jung-Eun Lee, et al.
Published: (2017-07-01) -
FAM83H is involved in the progression of hepatocellular carcinoma and is regulated by MYC
by: Kyoung Min Kim, et al.
Published: (2017-06-01) -
Retroviral restriction factors: new mechanisms of innate immunity
by: Goff Stephen P, et al.
Published: (2009-09-01) -
Universal immunotherapeutic strategy for hepatocellular carcinoma with exosome vaccines that engage adaptive and innate immune responses
by: Gao, X., et al.
Published: (2022) -
Identification of serum monocyte chemoattractant protein-1 and prolactin as potential tumor markers in hepatocellular carcinoma.
by: Who-Whong Wang, et al.
Published: (2013-01-01)